The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Bevacizumab for Cervical Cancer

Bradley Monk, MD
Published Online:5:35 PM, Tue July 22, 2014
Bradley Monk, MD, gynecologic oncologist, University of Arizona Cancer Center Phoenix Branch, discusses the utility of bevacizumab for the treatment of cervical cancer.

Clinical Pearls

  • Bevacizumab has been looked at in many solid tumors, including ovarian cancer.
  • Treatment options for patients with cervical cancer are limited.
  • Bevacizumab plus chemotherapy elicits a survival advantage in this population.
MORE: Bevacizumab Receives Priority Review for Advanced Cervical Cancer > >
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.